{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:38:38Z","timestamp":1790843918739,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["MH18501"],"award-info":[{"award-number":["MH18501"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.neuropharm.2010.10.025","type":"journal-article","created":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T08:13:08Z","timestamp":1288599188000},"page":"1187-1192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Huntington\u2019s Disease is a disorder of the corpus striatum: Focus on Rhes (Ras homologue enriched in the striatum)"],"prefix":"10.1016","volume":"60","author":[{"given":"Srinivasa","family":"Subramaniam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon H.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2010.10.025_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group","volume":"72","author":"Anon","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.410020406","article-title":"Huntington\u2019s chorea: selective depletion of activity of angiotensin coverting enzyme in the corpus striatum","volume":"2","author":"Arregui","year":"1977","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib4","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","article-title":"Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity","volume":"16","author":"Atwal","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib5","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.0511316103","article-title":"Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH","volume":"103","author":"Bae","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/hmg\/11.8.945","article-title":"Targeted disruption of huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behavior","volume":"11","author":"Chan","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib9","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/6.13.2205","article-title":"huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin","volume":"6","author":"Engelender","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJM197606102942402","article-title":"Huntington\u2019s chorea. Changes in neurotransmitter receptors in the brain","volume":"294","author":"Enna","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.mcn.2007.10.007","article-title":"The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons","volume":"37","author":"Errico","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9","article-title":"Rhes: a striatal-specific Ras homolog related to Dexras1","volume":"57","author":"Falk","year":"1999","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0896-6273(00)00095-7","article-title":"Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON","volume":"28","author":"Fang","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington\u2019s disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1101\/gad.887201","article-title":"Regulation of translation initiation by FRAP\/mTOR","volume":"15","author":"Gingras","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ng0896-442","article-title":"Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract","volume":"13","author":"Goldberg","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib19","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/MCB.24.10.4329-4340.2004","article-title":"Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1","volume":"24","author":"Hyun","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib20","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0896-6273(00)80439-0","article-title":"CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95","volume":"20","author":"Jaffrey","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib62","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1073\/pnas.261705799","article-title":"Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON","volume":"99","author":"Jaffrey","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/hmg\/ddp478","article-title":"SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7","volume":"19","author":"Janer","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ng0597-44","article-title":"HIP1, a human homologue of S.\u00a0cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain","volume":"16","author":"Kalchman","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib24","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","article-title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration","volume":"3","author":"Kaltenbach","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib25","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1074\/jbc.273.6.3129","article-title":"Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells","volume":"273","author":"Kemppainen","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ncb1478","article-title":"Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state","volume":"8","author":"Kitamura","year":"2006","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntington aggregates may not predict neuronal death in Huntington\u2019s disease","volume":"46","author":"Kuemmerle","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ncb1717","article-title":"Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4\/ubiquitin-mediated pathway","volume":"10","author":"Lallemand-Breitenbach","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington\u2019s disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib30","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1074\/jbc.M408430200","article-title":"Huntingtin interacting protein 1 (HIP1) regulates clathrin assembly through direct binding to the regulatory region of the clathrin light chain","volume":"280","author":"Legendre-Guillemin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib31","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1523\/JNEUROSCI.18-04-01261.1998","article-title":"Interaction of huntingtin-associated protein with dynactin P150Glued","volume":"18","author":"Li","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin\u2013protein interactions and the pathogenesis of Huntington\u2019s disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib33","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1523\/JNEUROSCI.23-17-06956.2003","article-title":"Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington\u2019s disease","volume":"23","author":"Li","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/378398a0","article-title":"A Huntingtin-associated protein enriched in brain with implications for pathology","volume":"378","author":"Li","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2009.06.049","article-title":"ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line","volume":"1286","author":"Liang","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib36","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/hmg\/ddm360","article-title":"AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington\u2019s disease","volume":"17","author":"Lievens","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib37","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1074\/jbc.M509806200","article-title":"Interaction of huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons","volume":"281","author":"McGuire","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib38","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1093\/emboj\/cdg334","article-title":"Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking","volume":"22","author":"Metzler","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/hmg\/ddi071","article-title":"A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure","volume":"14","author":"Poirier","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib40","doi-asserted-by":"crossref","first-page":"10855","DOI":"10.1074\/jbc.M804813200","article-title":"Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells","volume":"284","author":"Ratovitski","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib41","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1523\/JNEUROSCI.1251-06.2006","article-title":"Regulation of intracellular trafficking of huntingtin-associated protein-1 is critical for TrkA protein levels and neurite outgrowth","volume":"26","author":"Rong","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cell.2004.06.022","article-title":"Huntington\u2019s disease: new paths to pathogenesis","volume":"118","author":"Ross","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nchembio883","article-title":"Small molecules enhance autophagy and reduce toxicity in Huntington\u2019s disease models","volume":"3","author":"Sarkar","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib45","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib47","first-page":"124","article-title":"Huntington\u2019s disease: treatment with muscimol, a GABA-mimetic drug","volume":"102","author":"Shoulson","year":"1977","journal-title":"Trans. Am. Neurol. Assoc."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib48","doi-asserted-by":"crossref","first-page":"12717","DOI":"10.1523\/JNEUROSCI.3670-09.2009","article-title":"Neurotransmitters, receptors, and second messengers galore in 40 years","volume":"29","author":"Snyder","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib49","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1128\/MCB.24.13.5788-5796.2004","article-title":"Rhes is involved in striatal function","volume":"24","author":"Spano","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib50","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","article-title":"Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism","volume":"24","author":"Spires","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1092194","article-title":"SUMO modification of Huntingtin and Huntington\u2019s disease pathology","volume":"304","author":"Steffan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib52","doi-asserted-by":"crossref","first-page":"20428","DOI":"10.1074\/jbc.C110.127191","article-title":"RHES, a physiologic regulator of sumoylation, enhances cross-sumoylation among the basic sumoylation enzymes E1 and UBC9","volume":"285","author":"Subramaniam","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib53","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.1172871","article-title":"Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity","volume":"324","author":"Subramaniam","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib54","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ncb1716","article-title":"RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation","volume":"10","author":"Tatham","year":"2008","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0014-2999(84)90737-4","article-title":"Barbiturate recognition site on the GABA\/benzodiazepine receptor complex is distinct from the picrotoxinin\/TBPS recognition site","volume":"106","author":"Trifiletti","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.onc.1207161","article-title":"The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors","volume":"23","author":"Vargiu","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2010.10.025_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(01)00140-1","article-title":"Thyroid hormone regulation of rhes, a novel Ras homolog gene expressed in the striatum","volume":"94","author":"Vargiu","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib58","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/hmg\/10.17.1807","article-title":"The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-binding protein involved in receptor-mediated endocytosis","volume":"10","author":"Waelter","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib59","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","article-title":"Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington\u2019s disease","volume":"17","author":"Wang","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-4-11","article-title":"Inducible mutant huntingtin expression in HN10 cells reproduces Huntington\u2019s disease-like neuronal dysfunction","volume":"4","author":"Weiss","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2010.10.025_bib61","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.febslet.2008.08.008","article-title":"Arsenic trioxide stimulates SUMO-2\/3 modification leading to RNF4-dependent proteolytic targeting of PML","volume":"582","author":"Weisshaar","year":"2008","journal-title":"FEBS Lett."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T13:51:32Z","timestamp":1706017892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390810002959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":61,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0028390810002959"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.025","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huntington\u2019s Disease is a disorder of the corpus striatum: Focus on Rhes (Ras homologue enriched in the striatum)","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}